These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8030046)

  • 21. The development of graft versus host disease in the immunologically compromised recipient of a small bowel allograft.
    Moynihan HL; Stangl MJ; Langrehr J; Lee KK; Banner B; Schraut WH
    Transplant Proc; 1990 Aug; 22(4):2055-7. PubMed ID: 2389520
    [No Abstract]   [Full Text] [Related]  

  • 22. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract]   [Full Text] [Related]  

  • 23. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 24. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 25. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.
    Kobayashi E; Kamada N; Enosawa S; Toyama N; Lord R; Stamatiou S; Delriviere L; Miyata M
    Transplant Proc; 1994 Jun; 26(3):1575-7. PubMed ID: 8030042
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplant Proc; 1995 Jun; 27(3):2112-4. PubMed ID: 7792902
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum.
    Shaffer D; Maki T; DeMichele SJ; Karlstad MD; Bistrian BR; Balogh K; Monaco AP
    Transplantation; 1988 Feb; 45(2):262-9. PubMed ID: 3125634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 31. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of donor pretreatment on graft-versus-host disease (GVHD) after rat small-bowel transplantation (SBTX).
    Matsumoto S; Tanaka S; Orita K
    Transplant Proc; 1994 Aug; 26(4):2306-8. PubMed ID: 8066758
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism.
    Orloff MS; Orloff SL; DeMara EM; Coppage ML; Leong N; Fallon MA
    Transplant Proc; 1994 Jun; 26(3):1585-6. PubMed ID: 8030048
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 35. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract]   [Full Text] [Related]  

  • 36. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes.
    Odorico JS; Barker CF; Markmann JF; Posselt AM; Naji A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):295-6. PubMed ID: 8438306
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
    Xiao F; Foster PF; Sankary HN; Kociss K; Templeton AC; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1167-8. PubMed ID: 1604572
    [No Abstract]   [Full Text] [Related]  

  • 39. NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation.
    Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Maffei FA; Van Thiel DH
    Transplant Proc; 1994 Jun; 26(3):1626. PubMed ID: 8030063
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective mesenteric lymphoid irradiation eliminates the effector cells of lethal graft-versus-host disease while protecting radiosensitive intestinal tissue.
    Hasuike Y; Shaked A; Monden M; Shiraishi M; Farmer D; Holly EG; Busuttil RW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1196-7. PubMed ID: 8442085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.